CleanAI: The Next Frontier in Climate Tech Investment

CleanAI: The Next Frontier in Climate Tech Investment

A newly released State of CleanAI report from the Toronto-based CleanAI Initiative delivers a compelling snapshot of a sector quietly revolutionizing the clean economy transition. This sector is the application of artificial intelligence (AI) to climate solutions, collectively known as cleanAI. The report points to a niche subsector that merges AI and sustainability moving rapidly […]

Read More
 Sun Summit Minerals to Present at the 51st Annual New Orleans Investment Conference, November 2-5, 2025

Sun Summit Minerals to Present at the 51st Annual New Orleans Investment Conference, November 2-5, 2025

Sun Summit Minerals Corp. (TSXV: SMN,OTC:SMREF) (OTCQB: SMREF) (‘Sun Summit’ or the ‘Company’) is pleased to announce that it will be attending and presenting at the 51st Annual New Orleans Investment Conference, taking place November 2–5, 2025 at the Hilton New Orleans Riverside. Niel Marotta, CEO and Director, will host a Sunrise Session presentation on Tuesday, […]

Read More
 Quimbaya Gold Announces C$10 Million Bought Deal Financing

Quimbaya Gold Announces C$10 Million Bought Deal Financing

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./ Quimbaya Gold Inc. (‘Quimbaya’ or the ‘Company’) (CSE: QIM,OTC:QIMGF) (OTCQB: QIMGF) (FSE: K05) is pleased to announce that it has entered into an agreement with Stifel Canada […]

Read More
 Top 4 Canadian Biotech Stocks of 2025

Top 4 Canadian Biotech Stocks of 2025

Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to companies pursuing cutting-edge therapies and medical technologies. Read on to learn what’s been driving these Canadian biotech firms. 1. Eupraxia Pharmaceuticals (TSX:EPRX) Year-on-year gain: 141.23 percentMarket cap: C$410.85 millionShare price: C$8.25 Eupraxia Pharmaceuticals […]

Read More